[HTML][HTML] The emergence of omicron: challenging times are here again!
T Singhal - Indian journal of pediatrics, 2022 - Springer
COVID-19 has been reported to have caused more than 286 million cases and 5.4 million
deaths till date. COVID variants have appeared at regular intervals—alpha, beta, gamma …
deaths till date. COVID variants have appeared at regular intervals—alpha, beta, gamma …
[HTML][HTML] The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: lessons learned from major clinical studies
SARS-CoV-2 has spread across the globe in no time. In the beginning, people suffered due
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still …
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still …
[HTML][HTML] Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients
A Jayk Bernal, MM Gomes da Silva… - … England Journal of …, 2022 - Mass Medical Soc
Background New treatments are needed to reduce the risk of progression of coronavirus
disease 2019 (Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is …
disease 2019 (Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is …
[HTML][HTML] Seroconversion rates following COVID-19 vaccination among patients with cancer
As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we …
Alpha to Omicron: disease severity and clinical outcomes of major SARS-CoV-2 variants
FP Esper, TM Adhikari, ZJ Tu, YW Cheng… - The Journal of …, 2023 - academic.oup.com
Background Four severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
predominated in the United States since 2021. Understanding disease severity related to …
predominated in the United States since 2021. Understanding disease severity related to …
[HTML][HTML] Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Pan-betacoronavirus neutralizing antibodies may hold the key to developing broadly
protective vaccines against novel pandemic coronaviruses and to more effectively respond …
protective vaccines against novel pandemic coronaviruses and to more effectively respond …
[HTML][HTML] Therapeutics for COVID-19 and post COVID-19 complications: An update
Since its inception in late December 2020 in China, novel coronavirus has affected the
global socio-economic aspect. Currently, the world is seeking safe and effective treatment …
global socio-economic aspect. Currently, the world is seeking safe and effective treatment …
Shifting to serious illness communication
J Jacobsen, R Bernacki, J Paladino - Jama, 2022 - jamanetwork.com
Advance care planning originally focused on the completion of advance directives and tries
to address this need by preparing patients for decision-making …
to address this need by preparing patients for decision-making …
[HTML][HTML] Broadly-neutralizing antibodies against emerging SARS-CoV-2 variants
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
have become a major concern in the containment of current pandemic. The variants …
have become a major concern in the containment of current pandemic. The variants …
[HTML][HTML] A systematic review of vaccine breakthrough infections by SARS-CoV-2 delta variant
M Zhang, Y Liang, D Yu, B Du, W Cheng… - … journal of biological …, 2022 - ncbi.nlm.nih.gov
Vaccines are proving to be highly effective in controlling hospitalization and deaths
associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …
associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …